JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Shares Down 0.2% – Time to Sell?

JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC)’s stock price traded down 0.2% during mid-day trading on Friday . The company traded as low as $57.57 and last traded at $57.57. 805 shares were traded during trading, a decline of 10% from the average session volume of 895 shares. The stock had previously closed at $57.67.

JPMorgan Healthcare Leaders ETF Price Performance

The firm’s fifty day moving average price is $56.01 and its 200-day moving average price is $57.20. The company has a market capitalization of $11.51 million, a price-to-earnings ratio of 22.43 and a beta of 0.44.

Institutional Trading of JPMorgan Healthcare Leaders ETF

Several large investors have recently made changes to their positions in JDOC. Sanctuary Advisors LLC increased its stake in shares of JPMorgan Healthcare Leaders ETF by 12.7% during the 4th quarter. Sanctuary Advisors LLC now owns 6,359 shares of the company’s stock worth $368,000 after purchasing an additional 718 shares during the last quarter. Blue Water Asset Management purchased a new stake in shares of JPMorgan Healthcare Leaders ETF during the 4th quarter worth approximately $237,000. Ignite Planners LLC increased its stake in shares of JPMorgan Healthcare Leaders ETF by 136.8% during the 4th quarter. Ignite Planners LLC now owns 9,460 shares of the company’s stock worth $553,000 after purchasing an additional 5,465 shares during the last quarter. Krilogy Financial LLC purchased a new position in JPMorgan Healthcare Leaders ETF in the 3rd quarter valued at approximately $325,000. Finally, Jane Street Group LLC purchased a new position in JPMorgan Healthcare Leaders ETF in the 2nd quarter valued at approximately $1,166,000.

About JPMorgan Healthcare Leaders ETF

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.